PMS2 and neoplasm: MLH1 combines with PMS2 to form a heterodimer, and the combined deletion of MLH1 and PMS2 is a characteristic of patients with MLH1 mutations, while the deletion of PMS2 protein in tumor tissue indicates a germline mutation in PMS2 (13).